Market Cap 113.03M
Revenue (ttm) 0.00
Net Income (ttm) -26.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 110,800
Avg Vol 309,046
Day's Range N/A - N/A
Shares Out 89.70M
Stochastic %K 22%
Beta 1.93
Analysts Strong Sell
Price Target $5.17

Company Profile

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 201...

Industry: Biotechnology
Sector: Healthcare
Phone: 267-225-7416
Address:
2001 Market Street, Suite 3915 Unit #15, Philadelphia, United States
SpencerF
SpencerF Oct. 22 at 7:16 PM
$CNTX hope we didn’t miss last chance to dump
0 · Reply
bobmccusker
bobmccusker Oct. 22 at 1:25 PM
$CNTX https://www.tipranks.com/news/company-announcements/context-therapeutics-regains-nasdaq-compliance
1 · Reply
Jl37
Jl37 Oct. 21 at 5:03 PM
$CNTX terrible
1 · Reply
Jl37
Jl37 Oct. 20 at 4:52 PM
$CNTX started so well.
0 · Reply
TheJunksCalls
TheJunksCalls Oct. 20 at 1:20 PM
$KUKE <~~ Rinse & Repeat Play Every Year✅ KUKE went straight up everyday before market closed for weeks straight. I’m talking 10%+ everytime starting at 3:50 ET for the last couple years. After the loading was done it went up 200%+. Once it regains compliance it’s back in the dumps before they run it up again. This will run over $1+ any day/week. Process doesn’t chang here. $BULL $REI $ICCM $CNTX Long Plays 👊🏻
1 · Reply
LabPsycho
LabPsycho Oct. 20 at 1:16 PM
$BCAB @3SSA By my estimations, I think BCAB presently likely has almost near zero cash remaining. And what about reverse split / compliance - is this a concern? Their data looks encouraging but I dont know how they can stay afloat without massive dilution and any potential partner with $$$ knows BCAB needs them more than they need BCAB. To me, the most likely partnership or (gasp) [reverse] merger would be with $CNTX, which of course would really stick it to current investors of either company - its the Wall Street way.
1 · Reply
Jl37
Jl37 Oct. 17 at 5:14 PM
0 · Reply
HoHoHoHum
HoHoHoHum Oct. 17 at 1:50 PM
$CNTX compliance is now within reach!
1 · Reply
Jl37
Jl37 Oct. 16 at 4:45 PM
$CNTX terrible day
1 · Reply
JarvisFlow
JarvisFlow Oct. 16 at 12:40 PM
D. Boral Capital updates rating for Context Therapeutics ( $CNTX ) to Buy, target set at 9.
0 · Reply
Latest News on CNTX
Context Therapeutics: Undervalued Cancer Fighter

Jun 10, 2025, 7:10 AM EDT - 4 months ago

Context Therapeutics: Undervalued Cancer Fighter


SpencerF
SpencerF Oct. 22 at 7:16 PM
$CNTX hope we didn’t miss last chance to dump
0 · Reply
bobmccusker
bobmccusker Oct. 22 at 1:25 PM
$CNTX https://www.tipranks.com/news/company-announcements/context-therapeutics-regains-nasdaq-compliance
1 · Reply
Jl37
Jl37 Oct. 21 at 5:03 PM
$CNTX terrible
1 · Reply
Jl37
Jl37 Oct. 20 at 4:52 PM
$CNTX started so well.
0 · Reply
TheJunksCalls
TheJunksCalls Oct. 20 at 1:20 PM
$KUKE <~~ Rinse & Repeat Play Every Year✅ KUKE went straight up everyday before market closed for weeks straight. I’m talking 10%+ everytime starting at 3:50 ET for the last couple years. After the loading was done it went up 200%+. Once it regains compliance it’s back in the dumps before they run it up again. This will run over $1+ any day/week. Process doesn’t chang here. $BULL $REI $ICCM $CNTX Long Plays 👊🏻
1 · Reply
LabPsycho
LabPsycho Oct. 20 at 1:16 PM
$BCAB @3SSA By my estimations, I think BCAB presently likely has almost near zero cash remaining. And what about reverse split / compliance - is this a concern? Their data looks encouraging but I dont know how they can stay afloat without massive dilution and any potential partner with $$$ knows BCAB needs them more than they need BCAB. To me, the most likely partnership or (gasp) [reverse] merger would be with $CNTX, which of course would really stick it to current investors of either company - its the Wall Street way.
1 · Reply
Jl37
Jl37 Oct. 17 at 5:14 PM
0 · Reply
HoHoHoHum
HoHoHoHum Oct. 17 at 1:50 PM
$CNTX compliance is now within reach!
1 · Reply
Jl37
Jl37 Oct. 16 at 4:45 PM
$CNTX terrible day
1 · Reply
JarvisFlow
JarvisFlow Oct. 16 at 12:40 PM
D. Boral Capital updates rating for Context Therapeutics ( $CNTX ) to Buy, target set at 9.
0 · Reply
Jl37
Jl37 Oct. 15 at 2:08 PM
$CNTX checking in on the sleeper stock!
1 · Reply
DigiAnalyst
DigiAnalyst Oct. 15 at 2:11 AM
$CNTX Context Therapeutics Inc. is a STRONG BUY rating with +100% appreciation from current price. The average price target for the stock in 2025 is $5.20. Forecasts range from a low of $4.00 to a high of $9.00. This average price target represents a potential upside of 274.10% from the current price of $1.39.
0 · Reply
Jl37
Jl37 Oct. 13 at 2:14 PM
$CNTX welp she came back well like everything else out there and then fell out! Come on man!
0 · Reply
Jl37
Jl37 Oct. 10 at 9:59 PM
$CNTX dman! After hours more selling off
0 · Reply
VA_24
VA_24 Oct. 10 at 8:01 PM
$CNTX Closed neutral is amazing considering how shitty this day went
0 · Reply
MilsLearning
MilsLearning Oct. 10 at 6:04 PM
$CNTX Ever get bullied??? Trading stocks?? Me too!!! Well 🩳🖕🖕🔥🩳🖕🔥🩳🔥🖕🔥🩳
0 · Reply
J1476
J1476 Oct. 10 at 3:02 PM
0 · Reply
Jl37
Jl37 Oct. 10 at 1:53 PM
0 · Reply
GildedAge01
GildedAge01 Oct. 10 at 1:01 PM
$CNTX big runner today
0 · Reply
StockScanners
StockScanners Oct. 10 at 1:54 AM
$CNTX keep watch if this holds above 1.30
0 · Reply
J1476
J1476 Oct. 9 at 9:28 PM
$CNTX I f-ing love this stock!!
0 · Reply
VA_24
VA_24 Oct. 9 at 9:13 PM
$CNTX Data is expected early 2026 Time to let this run
1 · Reply